EUVIMEDEUVIMED entdecken
Crossref

Intravenous immunoglobulin alleviates Japanese encephalitis virus-induced peripheral neuropathy by inhibiting the ASM/ceramide pathway

Na Zhang, Guowei Wang, Liping Yang, Jinyuan Zhang, YanPing Yuan, Lijun Ma, Zhenhai Wang

International Immunopharmacology · 2024

DOI: 10.1016/j.intimp.2024.112083 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunopharmacology, 2024. Verfasst von Na Zhang und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Clinical Medicine, Ningxia Medical University, Yinchuan, Ningxia, China; Neurology Center, General Hospital of Ningxia Medical University, …. Hauptthemen laut MEDLINE: Ceramides, Encephalitis, Japanese, Immunoglobulins, Intravenous, Peripheral Nervous System Diseases. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 52 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Japanese encephalitis virus (JEV) infection is considered a global public health emergency. Severe peripheral neuropathy caused by JEV infection has increased disability and mortality rates in recent years. Because there are very few therapeutic options for JEV infection, prompt investigations of the ability of clinically safe, efficacious and globally available drugs to inhibit JEV infection and ameliorate peripheral neuropathy are urgently needed. In this study, we found that high doses of intravenous immunoglobulin, a function inhibitor of acid sphingomyelinase (FIASMA), inhibited acid sphingomyelinase (ASM) and ceramide activity in the serum and sciatic nerve of JEV-infected rats, reduced disease severity, reversed electrophysiological and histological abnormalities, significantly reduced circulating proinflammatory cytokine levels, inhibited Th1 and Th17 cell proliferation, and suppressed the infiltration of inflammatory CD4 + cells into the sciatic nerve. It also maintained the peripheral nerve-blood barrier without causing severe clinical side effects. In terms of the potential mechanisms, ASM was found to participate in immune cell differentiation and to activate immune cells, thereby exerting proinflammatory effects. Therefore, immunoglobulin is a FIASMA that reduces abnormal immune responses and thus targets the ASM/ceramide system to treat peripheral neuropathy caused by JEV infection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CeramidesEncephalitis, JapaneseImmunoglobulins, IntravenousPeripheral Nervous System DiseasesSphingomyelin PhosphodiesteraseAnimalsHumansMaleRatsCytokinesEncephalitis Virus, JapaneseRats, Sprague-DawleySciatic NerveSignal TransductionTh1 CellsTh17 Cells

Stichwörter der Autor:innen

Acid sphingomyelinaseCeramideIntravenous immunoglobulinJapanese encephalitis virusPeripheral neuropathy

Substanzen

CeramidesCytokinesImmunoglobulins, IntravenousSphingomyelin Phosphodiesterase

Autor:innen und Institutionen

  • School of Clinical Medicine, Ningxia Medical University, Yinchuan, Ningxia, China; Neurology Center, General Hospital of Ningxia Medical University, Yinchuan, Ningxia, China.
  • School of Clinical Medicine, Ningxia Medical University, Yinchuan, Ningxia, China.
  • Neurology Center, General Hospital of Ningxia Medical University, Yinchuan, Ningxia, China.
  • Department of Human Anatomy, Histology and Embryology, School of Basic Medicine, Ningxia Medical University, Yinchuan, Ningxia, China.
  • School of Clinical Medicine, Ningxia Medical University, Yinchuan, Ningxia, China; Diagnosis and Treatment Engineering Technology Research Center of Nervous System Diseases of Ningxia Hui Autonomous Region, General Hosp…

Zitieren

APA

Zhang, N., Wang, G., Yang, L., Zhang, J., Yuan, Y., Ma, L., & Wang, Z. (2024). Intravenous immunoglobulin alleviates Japanese encephalitis virus-induced peripheral neuropathy by inhibiting the ASM/ceramide pathway. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2024.112083

Vancouver

Zhang N, Wang G, Yang L, Zhang J, Yuan Y, Ma L, et al. Intravenous immunoglobulin alleviates Japanese encephalitis virus-induced peripheral neuropathy by inhibiting the ASM/ceramide pathway. International Immunopharmacology. 2024. doi:10.1016/j.intimp.2024.112083

BibTeX
@article{Zhang2024,
  author = {Zhang, Na and Wang, Guowei and Yang, Liping and Zhang, Jinyuan and Yuan, YanPing and Ma, Lijun and Wang, Zhenhai},
  title = {Intravenous immunoglobulin alleviates Japanese encephalitis virus-induced peripheral neuropathy by inhibiting the ASM/ceramide pathway},
  journal = {International Immunopharmacology},
  year = {2024},
  doi = {10.1016/j.intimp.2024.112083}
}
Kostenlos starten →